Literature DB >> 20098289

Heart transplantation in women with dilated cardiomyopathy.

Vera Regitz-Zagrosek1, George Petrov, Elke Lehmkuhl, Jaqueline M Smits, Birgit Babitsch, Claudia Brunhuber, Beate Jurmann, Julia Stein, Carola Schubert, Noel Bairey Merz, Hans Brendan Lehmkuhl, Roland Hetzer.   

Abstract

BACKGROUND: Dilated cardiomyopathy (DCM) is responsible for over half of all heart transplants. Fewer women with DCM undergo heart transplants than men with DCM; the reasons for this state of affairs are unclear. METHODS AND
RESULTS: We analyzed prospectively a cohort of 698 DCM patients who were referred to our heart transplant center. Only 15.5% of them were women. Women and men did not differ in age or ejection fraction (24%). Women were more frequently in New York Heart Association class III-IV, had lower exercise tolerance, worse pulmonary function, and poorer kidney function (all P<0.05) than men. Women were less commonly diabetic (14% vs. 23%; P<0.05). Similar percentages of women and men who were referred were transplanted; the women spent less time on the waiting list (153+/-37 days for women and 314+/-29 days for men; P<0.05). The 10-year survival rate of women and men after transplantation was similar (57% and 45%, respectively; P<0.203). We compared our current data to our overall experience from 1985 till date (n=972), and also with the Eurotransplant heart dataset. Similar to our current findings, far lower percentages of DCM patients in both cohorts were women, although the 10-year survival of female and male DCM patients after transplantation was not different.
CONCLUSIONS: Because women were referred with more severe heart failure but fewer relative contraindications, it seems that the option of transplantation is less intensely considered for women, particularly for those with comorbidities, by the referring physicians. Because women with DCM do as well as men after transplantation, efforts should be undertaken to improve referral of women.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20098289     DOI: 10.1097/TP.0b013e3181c35255

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  18 in total

1.  Sex and gender differences in health. Science & Society Series on Sex and Science.

Authors:  Vera Regitz-Zagrosek
Journal:  EMBO Rep       Date:  2012-06-29       Impact factor: 8.807

2.  The association of female sex with application of evidence-based practice recommendations for perioperative care in hip fracture surgery.

Authors:  Natalie Cho; Laura Boland; Daniel I McIsaac
Journal:  CMAJ       Date:  2019-02-11       Impact factor: 8.262

Review 3.  The Genetic Challenges and Opportunities in Advanced Heart Failure.

Authors:  Fady Hannah-Shmouni; Sara B Seidelmann; Sandra Sirrs; Arya Mani; Daniel Jacoby
Journal:  Can J Cardiol       Date:  2015-08-21       Impact factor: 5.223

4.  Sex differences and in-hospital outcomes in patients undergoing mechanical circulatory support implantation.

Authors:  Colleen K McIlvennan; JoAnn Lindenfeld; David P Kao
Journal:  J Heart Lung Transplant       Date:  2016-08-20       Impact factor: 10.247

Review 5.  Sex and gender differences in myocardial hypertrophy and heart failure.

Authors:  Vera Regitz-Zagrosek; Ute Seeland
Journal:  Wien Med Wochenschr       Date:  2011-03

Review 6.  Sex and gender differences in myocarditis and dilated cardiomyopathy.

Authors:  DeLisa Fairweather; Leslie T Cooper; Lori A Blauwet
Journal:  Curr Probl Cardiol       Date:  2013-01       Impact factor: 5.200

Review 7.  [Gender and cardiovascular diseases : Why we need gender medicine].

Authors:  V Regitz-Zagrosek
Journal:  Internist (Berl)       Date:  2017-04       Impact factor: 0.743

Review 8.  Determined to Fail--the Role of Genetic Mechanisms in Heart Failure.

Authors:  Elham Kayvanpour; Hugo A Katus; Benjamin Meder
Journal:  Curr Heart Fail Rep       Date:  2015-10

Review 9.  Sex differences in cardiovascular disease - Impact on care and outcomes.

Authors:  K H Humphries; M Izadnegahdar; T Sedlak; J Saw; N Johnston; K Schenck-Gustafsson; R U Shah; V Regitz-Zagrosek; J Grewal; V Vaccarino; J Wei; C N Bairey Merz
Journal:  Front Neuroendocrinol       Date:  2017-04-18       Impact factor: 8.333

10.  Sex-specific precision medicine: targeting CRT-D and other cardiovascular interventions to those most likely to benefit.

Authors:  Viviany R Taqueti; C Noel Bairey Merz
Journal:  Eur Heart J       Date:  2017-05-14       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.